Login to Your Account



Molecular Partners Gets $44M for its Rapid DARPin Scaffolds

By Cormac Sheridan


Wednesday, December 16, 2009
Molecular Partners AG, which is commercializing a protein scaffold technology, raised CHF46 million (US$44.2 million) in a Series B financing round led by Essex Woodlands Health Ventures, taking its total investment raised in the past two and a half years to CHF64.5 million.(BioWorld International)

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription